1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 2843-2851.
2. Leslie Citrome,1 Joseph P McEvoy,2 Mark S Todtenkopf,3 David McDonnell,4 and Peter J Weiden3. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. US National Library of Medicines, National Institutes of Health. 5 Sep 2019. [Accessed 27 Nov 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733343/
3. L Duggan 1, M Fenton, J Rathbone, R Dardennes, A El-Dosoky, S Indran. Olanzapine for schizophrenia. NIH: National Library of Medicine, National center of biotechnology Information Pubmed.gov. 18 Apr 2005. [Accessed 27 Nov 2020] https://pubmed.ncbi.nlm.nih.gov/15846619/
4. APL Swift Services (Malta) Limited; Electronic Medicines Compendium (EMC); [Revised on Mar 2020] [Accessed 27 Nov 2020] https://www.medicines.org.uk/emc/files/pil.3071.pdf